Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal ...

Advanced therapies are not linked to increased risk for serious or opportunistic infections, cancer, operations, or mortality among those with HIV and IBD.

For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...

A case report review examined complications, diagnosis, and treatment of genital Crohn's disease, a rare extraintestinal ...

Worthing firefighter Matt Wainwright is gearing up for the London Marathon — his first after ten years of applying.

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety ...

Johnson & Johnson has won U.S. Food and Drug Administration approval of its Icotyde treatment for certain patients with moderate-to-severe plaque psoriasis, a chronic autoimmune condition that causes ...

Evinature, a pioneer in evidence-based nutraceutical formulations designed to support digestive health and help individuals manage chronic bowel challenges, today announced that its proprietary CurQD ...

In patients with ulcerative colitis, initiation of biologic therapy within 12 months of diagnosis is linked to a lower risk ...

UConn fans are getting ready to cheer on the men's basketball team tonight at Elicit Brewing in Manchester. Mortgage rates are climbing, and that could make some people decide to hold off on buying a ...

Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics, family communication, and side effects.